Dr Reddy’s
Merck KGaA pushes biosimilars
February 12, 2014Research and Development, Sales and Marketing Dr Reddy's, Merck KGaA, biosimilars, dr reddys, generics
Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …
Dr Reddy’s offers €27m for Dutch formulation firm OctoPlus
October 23, 2012Manufacturing and Production Dr Reddy's, OctoPlus, outsourcing
India’s Dr Reddy’s Laboratories has signed an agreement to buy Netherlands-based formulation and drug delivery specialist OctoPlus in a €27m …
Dr Reddy’s grows UK manufacturing base
October 9, 2012Manufacturing and Production CPS, Dow Pharma, Dr Reddy's, Mirfield
India’s Dr Reddy’s Laboratories has said it plans to increase its manufacturing operations in the UK with a round of …
Dr Reddy’s says two plants clear FDA inspections
October 28, 2011Manufacturing and Production Dr Reddy's, FDA 483s, India, generics
Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …
Fujifilm plans generic venture with Dr. Reddy’s
August 2, 2011Manufacturing and Production Dr Reddy's, Fujifilm
Japanese photography and imaging company Fujifilm has taken another step into the healthcare sector with a new joint venture with …
Dr Reddy’s API plant in Mexico under FDA scrutiny
June 21, 2011Manufacturing and Production APIs, Dr Reddy's, FDA, GMP violations, pharma manufacturing news
Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …
Indian firm Dr Reddy’s opens UK site
April 12, 2011Sales and Marketing Cambridge, Chirotech, Dr Reddy's, India, generics
Indian firm Dr Reddy’s has confirmed the UK is still attractive for investment as it opens its new pharma services …
GSK sells antibiotics assets to Dr Reddy’s
November 24, 2010Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK
Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
